Harvard Business Review

MARCH 14, 2017

For industries that depend on innovation, sustaining it is a constant challenge. These two actions cost almost nothing compared to vast sums often spent — and arguably, often wasted — on efforts to foster innovation. Yet they have already generated tens of millions of dollars in value for Roivant.

Innovation 8

Innovation Company Incentives Industry 8

Harvard Business Review

MARCH 18, 2018

Why the Pharmaceutical Industry Is Booming in Japan. This also includes innovative systems for patient-requested care, promotion of self-medication, cloud-based record availability, and remote monitoring of patients in their homes. Conditional early approval expanded to cover innovative medical devices in July 2017.

Health Care 8

Health Care Industry Pharmaceuticals Content 8

Harvard Business Review

MAY 7, 2015

In the pharmaceutical industry, technology is transforming the sales process. A few decades ago, pharmaceutical companies promoted their products almost entirely through personal contact by salespeople with physicians. Consequently, pharmaceutical companies now look beyond the sales force to reach physicians.

Trends 8

Trends Technology Pharmaceuticals Team 8

Harvard Business Review

DECEMBER 5, 2016

Library leaders knew that given the immense changes brought on by digital innovations, as well as shifts in the communities that the Library served, it would need to evolve. Innovation communities had been used by Best Buy to grow its portion of the women’s consumer electronics market by $4.4b in less than five years.

Library 8

Library Strategy Reference Bottom-up 8

Harvard Business Review

FEBRUARY 4, 2013

Our research with members of the global C-suite, and with leading sustainability and innovation experts, has identified seven vectors of breakthrough change. Biology must move from the design table to the Board table," we were told by Janine Benyus, co-founder of consultancy Biomimicry 3.8. Business would change the rules of the game.

EPS 8

EPS Innovation CEO Pharmaceuticals 8

Harvard Business Review

DECEMBER 16, 2014

Obama reportedly felt the situation called for someone who could set priorities and help government agencies and private sector organizations of all kinds to collaborate and innovate. Top-down management simply will not get the innovation part of the job done. There are too many unknowns and too much risk for czar-like decision-making.

Management 8

Management Health Care NGO Crisis Management 8

Harvard Business Review

APRIL 13, 2012

It's depressing to realize how few of the teams in our lives use their human capital and opportunities well, when it comes to sustaining performance, innovating, or adapting. The drug development team leader at a major pharmaceutical company saw his role as the world-wide leader, not just within his country or therapeutic area.

Team 14

Team Sports Pharmaceuticals PR 14

Harvard Business Review

MARCH 17, 2011

A pharmaceutical company did something similar for safety scientists. IBM's innovation jams are also virtual thinking forums. Richard McDermott, PhD, is president of McDermott Consulting and a Visiting Academic Fellow at the Henley Business School. When assemblers need parts we don't ask them to go to a warehouse to pick them.

Document 14

Document Information Management Pharmaceuticals Cost 14

Harvard Business Review

JANUARY 30, 2014

Aetna just announced a pilot wellness initiative in which, collaborating with two little-known pharmaceutical companies, it would “outreach” to obese members to recommend two proprietary drugs that have failed in the marketplace likely due to unacceptable side-effect profiles. Are you doing wellness to your employees or for your employees?

Human Resources 8

Human Resources Guidelines Morale Insurance 8

Harvard Business Review

SEPTEMBER 26, 2011

Kasturi Rangan ; Michael Mauboussin of Legg Masson; Jeffrey Pfeffer of Stanford; and Michael Raynor of Deloitte Consulting. Some people may contend that given the high risks and many years it takes to develop a new drug, pharmaceutical companies are different animals from other firms. I disagree.

CEO 15

CEO Short-term Long-term Restructuring 15

Harvard Business Review

MARCH 27, 2018

voters and appeal to their hopes, neuroses, and fears, the political consulting firm needed to train its algorithm to predict and map personality traits. Unlike some pharmaceuticals, data-opolies do not charge consumers exorbitant prices. Less innovation in markets dominated by data-opolies. ” To target U.S.

Company 9

Company Advertising Incentives Engineering 9

Harvard Business Review

SEPTEMBER 20, 2013

Content Innovation. Or a healthcare data offering evaluating physicians’ perceptions on a new drug may be useful not only to brand managers at pharmaceutical companies, but also to portfolio managers at asset management firms seeking to find promising investment opportunities. In some cases, they’re right.

Execution 8

Execution Metrics Content Christensen 8

Harvard Business Review

FEBRUARY 20, 2014

But an awful lot of these jobs command very high-wages in law, finance, accounting, consulting, advertising, engineering, design, software, healthcare, scientific research, architecture, entertainment, hospitality, and many other areas. This may all change as China innovates and grows.

Intellectual Capital 8

Intellectual Capital Magazine Pharmaceuticals Creativity 8

Harvard Business Review

FEBRUARY 11, 2016

McKesson, the US-based pharmaceutical and health-care giant, benefits from external expertise as a strategic extension of its resources in areas such as business strategy and logistics support. Innovative companies are leading the way, applying a broader palette of talent options and relying on more varied types of relationships.

Agility 8

Agility Organization Resources Fixed Costs 8

Harvard Business Review

NOVEMBER 6, 2015

Many of the things we need to know to be successful – to innovate, collaborate, solve problems, and identify new opportunities – aren’t learned simply through schooling, training, or personal experience. only an expert sharing with a novice), they consistently receive higher client ratings on their performance.

Company 8

Company Licensing Knowledge Management Transportation 8

Harvard Business Review

SEPTEMBER 20, 2011

A vast ideological gap on macro-economic policy divides Washington and much of the nation, but there is almost universal agreement on one solution: innovation. Innovation is now perceived as a panacea for job creation, income generation, economic growth, dollar strength, and the revival of the U.S. as global hegemon.

Innovation 12

Innovation Supply Chain Offshoring Policies 12

Harvard Business Review

FEBRUARY 26, 2018

Regeneratives are pharmaceutical cell therapy products that replace or restore cells and tissues lost to disease or aging. “The Japanese want to be the regenerative medicine center of the world,” said Colin Lee Novick, managing director of the CJ Partners biotech consulting firm in Tokyo. Agilis Biotherapeutics, a U.S.

Pharmaceuticals 8

Pharmaceuticals Content Licensing Trends 8

Harvard Business Review

APRIL 19, 2016

has been an innovation superpower. Take a look at any significant innovation, such as an iPhone , and you’ll find that most, if not all, of the technology came from some government program. In the pharmaceutical industry, the monitoring process can be incredibly elaborate. vincent tsui FOR HBR. Since World War II, the U.S.

Innovation 8

Innovation Company Competitive Advantage Venture Funding 8

Harvard Business Review

FEBRUARY 20, 2018

Today, in pharmaceuticals and medical devices, in health care services and regenerative medicines, non-Japanese firms are learning from Japan’s markets before the aging trend arrives elsewhere in the world. From Finland to Israel, from Australia to Portugal, from the U.S.

Pharmaceuticals 8

Pharmaceuticals Company Content Health Care 8

Strategy Driven

JANUARY 24, 2011

Closing the Execution Gap : How Great Leaders and Their Companies Get Results by Richard Lepsinger If an organization can’t execute its plans and initiatives, nothing else matters: not the most solid, well thought-out strategy, not the most innovative business model, not even technological breakthroughs that could transform an industry.

Execution 67

Execution Company 360-Degree Feedback Cooper 67

Harvard Business Review

NOVEMBER 20, 2015

Compliance is crucial for pharmaceutical makers such as Abbott and Amgen – a “ Form 483 ” warning from an FDA inspector can shut down a drug facility in an instant and even land top executives in jail. This was the situation facing Collins Consulting , a Chicago area provider of contingent staffing services.

Supply Chain 8

Supply Chain Collins Golden Handcuff Pharmaceuticals 8

Harvard Business Review

OCTOBER 27, 2015

At UCB, a medium-sized pharmaceutical company headquartered in Belgium, Heresh Rezavandi and his managers Michelle Maddix-Sovero are leading a young strategic intelligence function that’s part of the strategic marketing practice. It also began innovating new services offerings to diversify its portfolio.

Marketing 8

Marketing Competitive Intelligence Porter How To 8

Harvard Business Review

OCTOBER 24, 2014

I have had a front row seat as companies have struggled to enter the emerging world of the Internet of Things — first, 10 years ago as a vice president at Ambient Devices , an MIT Media Lab spinoff that was a pioneer in commercializing IoT devices, and then as a consultant. It also took into account their roles in changing patient behavior.

Productivity 8

Productivity Products Company Engineering 8

Harvard Business Review

MAY 1, 2012

The BBC production Absolutely Fabulous (aka AbFab) featured me-generation Londoners who never met a fashion they couldn't love, a pharmaceutical they couldn't abuse, or a family member they couldn't disappoint. A great wave of cultural innovation followed, giving us creatures of a different kind. This show has precedents of its own.

Silverman 12

Silverman Pharmaceuticals Class Fashion 12

Great Leadership By Dan

FEBRUARY 7, 2014

After motivational ability, the senior executive traits most valued by organizations were: strong ability to manage change (51 percent); ability to identify and develop talent (46 percent); innovative thinking (30 percent); and consistent high performance (26 percent). years), while the pharmaceutical (5.7

Execution 283

Execution Company Press Release Survey 283

Harvard Business Review

JUNE 24, 2015

The f ive forces framework for strategy may be valid in one arena, blue ocean or open innovation in another, but each approach to strategy tends to be presented or perceived as a panacea. The firm can innovate to address a tired industry business model or can recognize a megatrend before others see and act on it.

Strategy 8

Strategy Competitive Advantage Environment Execution 8

Harvard Business Review

JUNE 23, 2015

I studied cross-functional teams in industries including communications, software, pharmaceuticals, semiconductors, agricultural, chemical, manufacturers, retail, utility, consulting, internet software, government, insurance, and banking. A PGT that is not routinely canceling some projects simply isn’t doing its job.

Team 8

Team Project Software Engineering 8